<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073824</url>
  </required_header>
  <id_info>
    <org_study_id>JOY 1515-03</org_study_id>
    <nct_id>NCT03073824</nct_id>
  </id_info>
  <brief_title>A Long-term Evaluation of a Novel Intravaginal Device</brief_title>
  <official_title>An Open-label Long-term Evaluation of a Novel Intravaginal Device in Female Patients Experiencing Sexual and Bladder Function Issues</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joylux, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Joylux, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An open-label long-term evaluation of a novel intravaginal device in female patients
      experiencing sexual and bladder function issues.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the long-term clinical efficacy of the vSculpt therapy on treating the pelvic
      floor area and vaginal tissue for females who experience bladder and sexual dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2017</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in Patient Quality of Life as Measured by Female Sexual Response Index</measure>
    <time_frame>365 days</time_frame>
    <description>Improvement in patient quality of life as measured by an improvement in Female Sexual Function Index (FSFI) scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in patient quality of life as measured by the Female Sexual Distress</measure>
    <time_frame>365 days</time_frame>
    <description>Improvement in patient quality of life as measured by an improvement Female Sexual Distress Score (FSDS) scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in patient quality of life as measured by the Urogenital Distress Inventory, Short Form (UDI-6)</measure>
    <time_frame>365 days</time_frame>
    <description>Improvement in patient quality of life as measured by an improvement Urogenital Distress Inventory, Short Form (UDI-6) scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in patient quality of life as measured by the Incontinence Impact Questionnaire, Short Form (IIQ-7)</measure>
    <time_frame>365 days</time_frame>
    <description>Improvement in patient quality of life as measured by an improvement Incontinence Impact Questionnaire, Short Form (IIQ-7) scores.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pelvic Floor Disorders</condition>
  <condition>Sexual Dysfunction</condition>
  <condition>Stress Incontinence</condition>
  <arm_group>
    <arm_group_label>vSculpt, model #VS1100</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A novel intravaginal device for females</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vSculpt</intervention_name>
    <description>Pelvic Floor Toning and Vaginal Rejuvenation Device</description>
    <arm_group_label>vSculpt, model #VS1100</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All study participants are required to be biological females (genotype XX) to
             participate

          -  Female participants will be of adult age, over 18

          -  Female participants with self-reported concerns with bladder and sexual function

          -  Female participants who have reliable and consistent computer and internet access on a
             daily basis

        Exclusion Criteria:

          -  Female participants shall not have an active sexually transmitted disease and/or
             infection

          -  Female participants who are actively undergoing chemotherapy or radiation

          -  Female participants who are currently taking any cancer-related or photosensitivity
             drugs

          -  Female participants who are pregnant, who may think they are pregnant, and/or actively
             trying to get pregnant during the clinical study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah De La Torre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle OB/GYN Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophia Sanchez</last_name>
    <phone>206-219-6444</phone>
    <email>clinicalstudy@joyluxinc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Egrari Non Invasive Center</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsey Miletta, RN BSN</last_name>
      <phone>425-827-8285</phone>
      <email>su@egrari.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Obstetrics and Gynecology Group</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah De La Torre, MD</last_name>
      <phone>206-799-7123</phone>
      <email>sdltconsult@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Pelvic Floor Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

